Preclinical • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PLK1 (Polo Like Kinase 1)
|
HR positive • HER-2 negative • PIK3CA mutation • CDK4 mutation
|
Ibrance (palbociclib) • Piqray (alpelisib) • onvansertib (PCM-075)